159 related articles for article (PubMed ID: 26275295)
1. The hMLH1 -93G>A Polymorphism and Risk of Ovarian Cancer in the Chinese Population.
Niu L; Li S; Liang H; Li H
PLoS One; 2015; 10(8):e0135822. PubMed ID: 26275295
[TBL] [Abstract][Full Text] [Related]
2. The hMLH1 promoter polymorphisms and cancer susceptibility in Asian populations: a meta-analysis.
He Y; Xu X; Chen H; Wang J; Xiong W; Xu Y; Liu J
Gene; 2013 Jul; 523(2):199-204. PubMed ID: 23587910
[TBL] [Abstract][Full Text] [Related]
3. Mismatch repair polymorphisms and colorectal polyps: hMLH1-93G>A variant modifies risk associated with smoking.
Yu JH; Bigler J; Whitton J; Potter JD; Ulrich CM
Am J Gastroenterol; 2006 Jun; 101(6):1313-9. PubMed ID: 16771955
[TBL] [Abstract][Full Text] [Related]
4. Expression and promoter methylation status of mismatch repair gene hMLH1 and hMSH2 in epithelial ovarian cancer.
Zhang H; Zhang S; Cui J; Zhang A; Shen L; Yu H
Aust N Z J Obstet Gynaecol; 2008 Oct; 48(5):505-9. PubMed ID: 19032668
[TBL] [Abstract][Full Text] [Related]
5. -93G-->A polymorphism of hMLH1 and risk of primary lung cancer.
Park SH; Lee GY; Jeon HS; Lee SJ; Kim KM; Jang SS; Kim CH; Lee WK; Kam S; Park RW; Kim IS; Jung TH; Park JY
Int J Cancer; 2004 Nov; 112(4):678-82. PubMed ID: 15382050
[TBL] [Abstract][Full Text] [Related]
6. Single nucleotide polymorphism in hMLH1 promoter and risk of tobacco-related oral carcinoma in high-risk Asian Indians.
Jha R; Gaur P; Sharma SC; Das SN
Gene; 2013 Sep; 526(2):223-7. PubMed ID: 23727610
[TBL] [Abstract][Full Text] [Related]
7. Polymorphisms in hMLH1 and risk of early-onset lung cancer in a southeast Chinese population.
An Y; Jin G; Wang H; Wang Y; Liu H; Li R; Wang H; Qian J; Sun W; Wang Y; Ma H; Miao R; Hu Z; Jin L; Wei Q; Shen H; Huang W; Lu D
Lung Cancer; 2008 Feb; 59(2):164-70. PubMed ID: 17870204
[TBL] [Abstract][Full Text] [Related]
8. [Study on genetic polymorphism of human mismatch repair gene hMLH1 and susceptibility of papillary thyroid carcinoma in Chinese Han people].
Shi WP; Bian JC; Jiang F; Ni HX; Zhu QX; Tang HW; Shen Q; Wu Y
Zhonghua Yu Fang Yi Xue Za Zhi; 2010 Mar; 44(3):235-41. PubMed ID: 20450746
[TBL] [Abstract][Full Text] [Related]
9. Genetic polymorphisms in
Si W; Kang S; Sun H; Chen J; Cao S; Li Y
Int J Gynecol Cancer; 2019 Sep; 29(7):1148-1155. PubMed ID: 31273068
[TBL] [Abstract][Full Text] [Related]
10. The prognostic significance of polymorphisms in hMLH1/hMSH2 for colorectal cancer.
Wang Y; Li G; Hu F; Bi H; Wu Z; Zhao X; Li Y; Li S; Li D; Cui B; Dong X; Zhao Y
Med Oncol; 2014 Jun; 31(6):975. PubMed ID: 24793746
[TBL] [Abstract][Full Text] [Related]
11. A polymorphism in the hMLH1 gene (-93G-->A) associated with lung cancer susceptibility and prognosis.
Shih CM; Chen CY; Lee IH; Kao WT; Wang YC
Int J Mol Med; 2010 Jan; 25(1):165-70. PubMed ID: 19956916
[TBL] [Abstract][Full Text] [Related]
12. A promoter polymorphism in the hMLH1 gene (-93G/A) associated with sporadic colorectal cancer.
Zhang LL; Tang XJ; Wang XY; Zhu YW; Peng XB; Gong L
Oncol Lett; 2016 Nov; 12(5):4035-4040. PubMed ID: 27895767
[TBL] [Abstract][Full Text] [Related]
13. The acquisition of hMLH1 methylation in plasma DNA after chemotherapy predicts poor survival for ovarian cancer patients.
Gifford G; Paul J; Vasey PA; Kaye SB; Brown R
Clin Cancer Res; 2004 Jul; 10(13):4420-6. PubMed ID: 15240532
[TBL] [Abstract][Full Text] [Related]
14. I219V polymorphism in hMLH1 gene in patients affected with ulcerative colitis.
Vietri MT; Riegler G; De Paola M; Simeone S; Boggia M; Improta A; Parisi M; Molinari AM; Cioffi M
Genet Test Mol Biomarkers; 2009 Apr; 13(2):193-7. PubMed ID: 19371218
[TBL] [Abstract][Full Text] [Related]
15. Polymorphism of DNA mismatch repair genes in endometrial cancer.
Poplawski T; Sobczuk A; Sarnik J; Pawlowska E; Blasiak J
Exp Oncol; 2015 Mar; 37(1):44-7. PubMed ID: 25804231
[TBL] [Abstract][Full Text] [Related]
16. Mismatch repair gene polymorphisms and association with lung cancer development.
Slováková P; Majerová L; Matáková T; Skereňová M; Kavcová E; Halašová E
Adv Exp Med Biol; 2015; 833():15-22. PubMed ID: 25252909
[TBL] [Abstract][Full Text] [Related]
17. Mismatch repair gene expression defects contribute to microsatellite instability in ovarian carcinoma.
Geisler JP; Goodheart MJ; Sood AK; Holmes RJ; Hatterman-Zogg MA; Buller RE
Cancer; 2003 Nov; 98(10):2199-206. PubMed ID: 14601090
[TBL] [Abstract][Full Text] [Related]
18. A role for methylation of the hMLH1 promoter in loss of hMLH1 expression and drug resistance in ovarian cancer.
Strathdee G; MacKean MJ; Illand M; Brown R
Oncogene; 1999 Apr; 18(14):2335-41. PubMed ID: 10327053
[TBL] [Abstract][Full Text] [Related]
19. Novel hMLH1 and hMSH2 germline mutations in African Americans with colorectal cancer.
Weber TK; Chin HM; Rodriguez-Bigas M; Keitz B; Gilligan R; O'Malley L; Urf E; Diba N; Pazik J; Petrelli NJ
JAMA; 1999 Jun 23-30; 281(24):2316-20. PubMed ID: 10386556
[TBL] [Abstract][Full Text] [Related]
20. Genetic polymorphisms of selected DNA repair genes, estrogen and progesterone receptor status, and breast cancer risk.
Lee KM; Choi JY; Kang C; Kang CP; Park SK; Cho H; Cho DY; Yoo KY; Noh DY; Ahn SH; Park CG; Wei Q; Kang D
Clin Cancer Res; 2005 Jun; 11(12):4620-6. PubMed ID: 15958648
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
